Sean S. Mahase, MD (@ssmahasemd) 's Twitter Profile
Sean S. Mahase, MD

@ssmahasemd

Radiation Oncologist, Medical Director #Education Vice Chair @PennStHershey l #RadOnc #btsm #pedonc #srs #oligomets #spine l 🏋️🧘🏻‍♂️🎨📘 l 💭= opinions

ID: 1206299150087790592

calendar_today15-12-2019 19:45:11

828 Tweet

264 Followers

443 Following

Joshua D. Palmer, MD (@joshuapalmermd) 's Twitter Profile Photo

Making some amazing progress towards being the first ever trial to place alpha particles in the brain for GBM. So excited for our patients and thankful to our huge team and Alpha Tau Medical. OhioStateRadOnc ASTRO ESTRO SNO EANO Ohio State Neurosurgery Residency

Making some amazing progress towards being the first ever trial to place alpha particles in the brain for GBM. So excited for our patients and thankful to our huge team and Alpha Tau Medical. <a href="/OhioStateRadOnc/">OhioStateRadOnc</a> <a href="/ASTRO_org/">ASTRO</a> <a href="/ESTRO_RT/">ESTRO</a> <a href="/NeuroOnc/">SNO</a> <a href="/EANOassociation/">EANO</a> <a href="/NeurosurgeryOSU/">Ohio State Neurosurgery Residency</a>
Eric K. Singhi, MD (@lungoncdoc) 's Twitter Profile Photo

New JTO & JTO CRR: Rapid intracranial response to tarlatamab in untreated SCLC brain mets Bingnan Zhang ▫️MD Anderson Cancer Center case series (n=10): 90% w/ response/stable dz ▫️No ⬆️ risk of CRS/ICANS despite multiple growing mets ▫️Tarlatamab may delay urgent 🧠 RT authors.elsevier.com/c/1kpZQ5Xq2QcX…

New <a href="/JTOonline/">JTO & JTO CRR</a>: Rapid intracranial response to tarlatamab in untreated SCLC brain mets <a href="/BZhangMD/">Bingnan Zhang</a> 

▫️<a href="/MDAndersonNews/">MD Anderson Cancer Center</a> case series (n=10): 90% w/ response/stable dz
▫️No ⬆️ risk of CRS/ICANS despite multiple growing mets
▫️Tarlatamab may delay urgent 🧠 RT

authors.elsevier.com/c/1kpZQ5Xq2QcX…
Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

A fantastic prospective report on H&N #reirradiation from the Tata Memorial group, one of the largest prospective H&N ReRT reports published. 📌 Patient selection = Crucial. Looking forward to detailed reporting of cumulative RT1 and RT2 dosimetry! sciencedirect.com/science/articl…

A fantastic prospective report on H&amp;N #reirradiation from the Tata Memorial group, one of the largest prospective H&amp;N ReRT reports published. 

📌 Patient selection = Crucial.

Looking forward to detailed reporting of cumulative RT1 and RT2 dosimetry! 

sciencedirect.com/science/articl…
Chris Jackson, MD MS (@chris_jacksonmd) 's Twitter Profile Photo

Our secondary analysis of ARST1431 looking at local control with radiotherapy for pediatric rhabdomyosarcoma was published this week in IJROBP - The Red Journal. Thanks to Dr. Suzanne Wolden and the rest of COG Soft Tissue Sarcoma Group for your mentorship. redjournal.org/article/S0360-…

Stanislav (Stas) Lazarev, MD (@staslazarev) 's Twitter Profile Photo

⚡️⚡️NEW STUDY - presented today at #ARS2025 in an oral talk by MS2 Yarelis Roque-Reyes from UCC School of Medicine, PR 🧠💥 Does whole brain RT (WBRT) help patients hospitalized with symptomatic leptomeningeal disease (LMD)? Our Mount Sinai Radiation Oncology study suggests: rarely — and in

⚡️⚡️NEW STUDY - presented today at #ARS2025 in an oral talk by MS2 Yarelis Roque-Reyes from UCC School of Medicine, PR

🧠💥 Does whole brain RT (WBRT) help patients hospitalized with symptomatic leptomeningeal disease (LMD)?

Our <a href="/MountSinaiRO/">Mount Sinai Radiation Oncology</a> study suggests: rarely — and in
Douglas Kondziolka (@dkondziolkacns) 's Twitter Profile Photo

A question commonly asked- what is the role of embolization?…Stereotactic Radiosurgery With Versus Without Neoadjuvant... : Neurosurgery journals.lww.com/neurosurgery/a…

Advances, an ASTRO Journal (@advances_astro) 's Twitter Profile Photo

REPRESENTATION MATTERS! Study finds that members of NCCN committees include: 48%- med onc 21%- surg onc 9%- rad onc (3% Chair; 23% VC) Emphasizes opportunity for growth as specialty inclusivity is critical to balance diversity of perspectives in management recommendations

REPRESENTATION MATTERS!

Study finds that members of NCCN committees include:
48%- med onc
21%- surg onc
9%- rad onc (3% Chair; 23% VC)

Emphasizes opportunity for growth as specialty inclusivity is critical to balance diversity of perspectives in management recommendations
Simon Lo (@simonlo21054188) 's Twitter Profile Photo

Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas - International Journal of Radiation Oncology, Biology, Physics redjournal.org/article/S0360-… Kudos to Joshua D. Palmer, MD Haley K. Perlow, MD for leading this effort!

Jonathan A. Tangsrivimol, MD (@jonytangs) 's Twitter Profile Photo

Proud to share my first paper on the Endoscopic Transorbital Approach, now published in J Neurol Surg B! This study highlights the Endoscopic Lateral Transorbital Approach (eLTOA) as a minimally invasive corridor to access anteromedial temporal lobe gliomas—for both biopsy and

Proud to share my first paper on the Endoscopic Transorbital Approach, now published in J Neurol Surg B!
This study highlights the Endoscopic Lateral Transorbital Approach (eLTOA) as a minimally invasive corridor to access anteromedial temporal lobe gliomas—for both biopsy and
Myrsini Ioakeim-Ioannidou, MD (@myrsiniioakeim) 's Twitter Profile Photo

In this new Editorial IJROBP - The Red Journal, we discuss the COG Atlas for germ cell tumors and support the recommendation by Alper Kahvecioglu MD and Melek Tugce Yilmaz MD to include the prepontine cistern in the whole ventricular volume. Shannon M MacDonald redjournal.org/article/S0360-… ASTRO

Jason Sheehan (@jasonpsheehan) 's Twitter Profile Photo

3D mixed reality imaging to plan brain tumor resections. The blue areas are important fiber tracts. Check out the latest study in the Journal of Neuro-Oncology by the team from Leeds (doi.org/10.1007/s11060…)

3D mixed reality imaging to plan brain tumor resections.  The blue areas are important fiber tracts.  Check out the latest study in the Journal of Neuro-Oncology by the team from Leeds (doi.org/10.1007/s11060…)
Bobby Koneru, MD (@konerumd) 's Twitter Profile Photo

I’m excited to share that our publication of the first modern American case series for the treatment of Osteoarthritis (OA) with Low Dose Radiotherapy (LDRT) is now published and available online in the red journal. The American patient population differs significantly from

I’m excited to share that our publication of the first modern American case series for the treatment of Osteoarthritis (OA) with Low Dose Radiotherapy (LDRT) is now published and available online in the red journal. 

The American patient population differs significantly from
Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

🧵1/ 🚨New case report out in Cureus: Face the Pain: Radiobiological and Clinical Considerations of Re-radiosurgery to the Trigeminal Nerve 👉 A deep dive into a unique case of medically refractory TGN in the setting of a petroclival meningioma. 🔗 doi.org/10.7759/cureus…

🧵1/ 

🚨New case report out in Cureus:

Face the Pain: Radiobiological and Clinical Considerations of Re-radiosurgery to the Trigeminal Nerve

👉 A deep dive into a unique case of medically refractory TGN in the setting of a petroclival meningioma.

🔗 doi.org/10.7759/cureus…
International Consortium on Meningiomas (ICOM) (@icomeningioma) 's Twitter Profile Photo

DOTATATE PET/MR represents a promising #ImagingBiomarker for response assessment in #meningiomas treated with #radiosurgery - this was the important finding from a recent study. Read about it now in #NeuroOncology: academic.oup.com/neuro-oncology…

DOTATATE PET/MR represents a promising #ImagingBiomarker for response assessment in #meningiomas treated with #radiosurgery - this was the important finding from a recent study. 

Read about it now in #NeuroOncology: academic.oup.com/neuro-oncology…
Alireza Mansouri (@dramansouri) 's Twitter Profile Photo

Honored to be recognized as the Pennsylvania Medical Society Top 40 under 40. Grateful for my patients, colleagues and mentors who inspire me daily to keep pushing for better answers. Sean S. Mahase, MD Penn State Neurosurgery PennStateGME #Cancer bit.ly/43tLTZw

Honored to be recognized as the Pennsylvania Medical Society Top 40 under 40. Grateful for my patients, colleagues and mentors who inspire me daily to keep pushing for better answers. 
<a href="/SSMahaseMD/">Sean S. Mahase, MD</a>
<a href="/PennStNeurosurg/">Penn State Neurosurgery</a>
<a href="/PennStateGME/">PennStateGME</a>
#Cancer 
bit.ly/43tLTZw
Joshua D. Palmer, MD (@joshuapalmermd) 's Twitter Profile Photo

Pituitary metastasis are not common, but SRS is a terrific therapy for control. In this large series LC was 93% at 1 year. Don’t shy away, these can be controlled with low morbidity, don’t overlook this area on MRI. Intl Radiosurgery Research Foundation OhioStateRadOnc pubmed.ncbi.nlm.nih.gov/40442537/